• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

条件分布建模作为协变量模拟的一种替代方法:与联合多元正态和自举技术的比较。

Conditional distribution modeling as an alternative method for covariates simulation: Comparison with joint multivariate normal and bootstrap techniques.

机构信息

Pharmetheus AB, Uppsala, Sweden.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):330-339. doi: 10.1002/psp4.12613.

DOI:10.1002/psp4.12613
PMID:33793067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8099438/
Abstract

Clinical trial simulation (CTS) is a valuable tool in drug development. To obtain realistic scenarios, the subjects included in the CTS must be representative of the target population. Common ways of generating virtual subjects are based upon bootstrap (BS) procedures or multivariate normal distributions (MVNDs). Here, we investigated the performance of an alternative method based on conditional distributions (CDs). Covariate data from a hypertension drug development program were used. The methods were evaluated based on the original data set (internal evaluation) and on their ability to reproduce an older, unobserved population (extrapolation). Similar results were obtained in the internal evaluation for summary statistics, yet BS was able to preserve the correlation structure of the empirical distribution, which was not adequately reproduced by MVND; CD was in between BS and MVND. BS does not allow to extrapolate to an unobserved population. When the data set used to inform the extrapolation was well approximated by an MVND, the results from CD and MVND were comparable. However, improved extrapolation performance was observed for CD when deviations from normality assumptions occurred. If CTS is used to simulate within the observed distribution, BS is the preferred method. When extrapolating to new populations, a parametric method like CD/MVND is needed. In case the empirical multivariate distribution is characterized by linearly related covariates and unimodal marginal distributions, MVND can be used because of the simpler statistical framework and well-established use; however, if uncertainty about the MVND assumptions exists, CD will increase the confidence in the simulations compared to MVND.

摘要

临床试验模拟(CTS)是药物开发的有价值的工具。为了获得现实场景,CTS 中包含的受试者必须代表目标人群。生成虚拟受试者的常见方法基于自举(BS)程序或多元正态分布(MVND)。在这里,我们研究了基于条件分布(CD)的替代方法的性能。使用高血压药物开发计划中的协变量数据。根据原始数据集(内部评估)和它们复制旧的、未观察到的人群的能力(外推)对方法进行评估。在内部评估中,对于汇总统计数据,获得了相似的结果,但 BS 能够保留经验分布的相关结构,而 MVND 无法充分复制;CD 处于 BS 和 MVND 之间。BS 不允许外推到未观察到的人群。当用于告知外推的数据集很好地被 MVND 逼近时,CD 和 MVND 的结果是可比的。然而,当出现偏离正态性假设时,CD 观察到了改进的外推性能。如果 CTS 用于模拟观察到的分布内,BS 是首选方法。当外推到新的人群时,需要像 CD/MVND 这样的参数方法。如果经验多元分布的特征是具有线性相关协变量和单峰边际分布,则由于更简单的统计框架和成熟的用途,MVND 可以使用;然而,如果对 MVND 假设存在不确定性,CD 将比 MVND 增加对模拟的信心。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/c14b3211cb4e/PSP4-10-330-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/1679f33dbc21/PSP4-10-330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/b0da444ed555/PSP4-10-330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/26376d3c773e/PSP4-10-330-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/8d25dfe9a03c/PSP4-10-330-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/c14b3211cb4e/PSP4-10-330-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/1679f33dbc21/PSP4-10-330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/b0da444ed555/PSP4-10-330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/26376d3c773e/PSP4-10-330-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/8d25dfe9a03c/PSP4-10-330-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0344/8099438/c14b3211cb4e/PSP4-10-330-g004.jpg

相似文献

1
Conditional distribution modeling as an alternative method for covariates simulation: Comparison with joint multivariate normal and bootstrap techniques.条件分布建模作为协变量模拟的一种替代方法:与联合多元正态和自举技术的比较。
CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):330-339. doi: 10.1002/psp4.12613.
2
Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques.通过多变量和离散重采样技术生成虚拟患者
Pharm Res. 2015 Oct;32(10):3228-37. doi: 10.1007/s11095-015-1699-x. Epub 2015 May 21.
3
Simulation of correlated continuous and categorical variables using a single multivariate distribution.使用单一多元分布对相关连续变量和分类变量进行模拟。
J Pharmacokinet Pharmacodyn. 2006 Dec;33(6):773-94. doi: 10.1007/s10928-006-9033-1. Epub 2006 Oct 12.
4
Virtual Patient Simulation Using Copula Modeling.基于 Copula 模型的虚拟患者模拟。
Clin Pharmacol Ther. 2024 Apr;115(4):795-804. doi: 10.1002/cpt.3099. Epub 2023 Nov 24.
5
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.
6
Generation of virtual patient data for in-silico cardiomyopathies drug development using tree ensembles: a comparative study.使用树集成生成虚拟患者数据用于计算机模拟心肌病药物开发:一项比较研究
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5343-5346. doi: 10.1109/EMBC44109.2020.9176567.
7
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models.线性混合效应模型中用于估计参数不确定性的自助法比较。
Pharm Stat. 2013 May-Jun;12(3):129-40. doi: 10.1002/pst.1561. Epub 2013 Mar 4.
8
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.评价 Bootstrap 方法在估计非线性混合效应模型中参数不确定性的应用:群体药代动力学中的模拟研究。
J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):15-33. doi: 10.1007/s10928-013-9343-z. Epub 2013 Dec 8.
9
Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data.使用患者水平模拟模型推断临床试验数据时准确反映不确定性。
Med Decis Making. 2020 May;40(4):460-473. doi: 10.1177/0272989X20916442. Epub 2020 May 20.
10
Assessment of Bayesian expected power via Bayesian bootstrap.贝叶斯 bootstrap 法评估贝叶斯功效。
Stat Med. 2018 Oct 30;37(24):3471-3485. doi: 10.1002/sim.7826. Epub 2018 Jun 25.

引用本文的文献

1
Information-theoretic evaluation of covariate distributions models.协变量分布模型的信息论评估
J Pharmacokinet Pharmacodyn. 2025 Mar 27;52(2):21. doi: 10.1007/s10928-025-09968-5.
2
Sampling from covariate distribution may not always be necessary in PK/PD simulations: illustrative examples with antibiotics.在药代动力学/药效学(PK/PD)模拟中,并非总是需要从协变量分布中进行抽样:以抗生素为例进行说明。
J Pharmacokinet Pharmacodyn. 2025 Mar 4;52(2):19. doi: 10.1007/s10928-025-09967-6.
3
GAN-Based Novel Approach for Generating Synthetic Medical Tabular Data.

本文引用的文献

1
Synthetic and External Controls in Clinical Trials - A Primer for Researchers.临床试验中的合成对照与外部对照——研究人员入门指南
Clin Epidemiol. 2020 May 8;12:457-467. doi: 10.2147/CLEP.S242097. eCollection 2020.
2
Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development.通过定量药理学转变翻译,以在药物发现和开发中做出高影响力决策。
Clin Pharmacol Ther. 2020 Jun;107(6):1285-1289. doi: 10.1002/cpt.1667. Epub 2019 Nov 10.
3
The use of a predictive statistical model to make a virtual control arm for a clinical trial.
基于生成对抗网络的合成医学表格数据生成新方法。
Bioengineering (Basel). 2024 Dec 18;11(12):1288. doi: 10.3390/bioengineering11121288.
4
Synthetic data generation methods in healthcare: A review on open-source tools and methods.医疗保健领域的合成数据生成方法:关于开源工具和方法的综述
Comput Struct Biotechnol J. 2024 Jul 9;23:2892-2910. doi: 10.1016/j.csbj.2024.07.005. eCollection 2024 Dec.
5
Generation of realistic virtual adult populations using a model-based copula approach.利用基于模型的 Copula 方法生成逼真的虚拟成年人群。
J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):735-746. doi: 10.1007/s10928-024-09929-4. Epub 2024 Jun 6.
6
Increasing transparency in machine learning through bootstrap simulation and shapely additive explanations.通过引导模拟和 Shapley 加性解释提高机器学习的透明度。
PLoS One. 2023 Feb 23;18(2):e0281922. doi: 10.1371/journal.pone.0281922. eCollection 2023.
7
Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure-response relationships for large-molecule oncology drugs.Cox 比例风险模型在恢复大型分子肿瘤药物混杂暴露反应关系的真实情况方面的性能。
CPT Pharmacometrics Syst Pharmacol. 2022 Nov;11(11):1511-1526. doi: 10.1002/psp4.12859. Epub 2022 Sep 16.
8
Efficient and relevant stepwise covariate model building for pharmacometrics.用于药代动力学的高效相关逐步协变量模型构建。
CPT Pharmacometrics Syst Pharmacol. 2022 Sep;11(9):1210-1222. doi: 10.1002/psp4.12838. Epub 2022 Jul 19.
9
Welcome to the statistics and pharmacometrics themed issue.欢迎阅读本期统计与药代动力学主题专刊。
CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):273-274. doi: 10.1002/psp4.12625.
使用预测统计模型为临床试验创建虚拟对照臂。
PLoS One. 2019 Sep 4;14(9):e0221336. doi: 10.1371/journal.pone.0221336. eCollection 2019.
4
A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic Patients.基于药物浓度阈值的不依从性检测的受试者工作特征框架-在精神分裂症患者模拟利培酮数据中的应用。
AAPS J. 2019 Mar 14;21(3):40. doi: 10.1208/s12248-019-0299-9.
5
Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives.模型引导的药物发现和开发:当前行业良好实践和监管期望及未来展望。
CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):87-96. doi: 10.1002/psp4.12372. Epub 2019 Feb 1.
6
Receiver Operating Characteristic Analysis and Clinical Trial Simulation to Inform Dose Titration Decisions.受试者工作特征分析和临床试验模拟用于辅助剂量滴定决策。
CPT Pharmacometrics Syst Pharmacol. 2018 Nov;7(11):771-779. doi: 10.1002/psp4.12354. Epub 2018 Oct 15.
7
Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.疾病、药物和患者依从性对儿科 HIV 抗病毒治疗效果的影响。
Expert Opin Drug Metab Toxicol. 2017 May;13(5):497-511. doi: 10.1080/17425255.2017.1277203. Epub 2017 Jan 23.
8
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.博纳吐单抗对比成人复发/难治性急性淋巴细胞白血病的历史标准疗法。
Blood Cancer J. 2016 Sep 23;6(9):e473. doi: 10.1038/bcj.2016.84.
9
Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part II: Bayesian Approaches.儿科试验中替代研究设计的基于模型评估。第二部分:贝叶斯方法。
CPT Pharmacometrics Syst Pharmacol. 2016 Aug;5(8):402-10. doi: 10.1002/psp4.12092. Epub 2016 Aug 17.
10
Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches.基于模型的儿科试验替代研究设计评估。第一部分:频率论方法。
CPT Pharmacometrics Syst Pharmacol. 2016 Jun;5(6):305-12. doi: 10.1002/psp4.12083. Epub 2016 Jun 1.